Hillhouse Capital Management
Hillhouse co-leads $93m Series B for US biotech firm
Hillhouse Capital and Quan Capital have led a $93 million Series B round for NextCure, a US-based biopharmaceutical company focused on cancer and other diseases.
PE-backed Chinese fashion platform Mogujie files for US IPO
Chinese online shopping and social networking business Mogujie has filed to list in the US. The company's investors include Tencent Holdings, Trustbridge Partners, and Hillhouse Capital.
PE-backed CStone files for Hong Kong IPO
CStone Pharmaceuticals, a cancer-focused Chinese biopharmaceutical developer with a number of PE and VC backers, has filed for an IPO in Hong Kong.
Hillhouse, VMG target consumer brands
Hillhouse Capital and VMG Partners, a US-based PE firm focused on the consumer sector, have formed a strategic partnership to invest up to $100 million in innovative consumer brands worldwide.
3Q analysis: Favoring the few
Brand names dominate Asia fundraising to an unprecedented degree; China IPOs continue despite weakening markets; Taiwan, Australia and Singapore deliver an unlikely investment boost
Hillhouse, Tencent back Chinese low-cost retailer Miniso
Miniso, a fast-growing Chinese low-cost retailer, has received RMB1 billion ($145.5 million) in funding from Tencent Holdings and Hillhouse Capital. The proceeds will be used for international expansion and smart retail initiatives.
Asia fundraising: The $10b club
Hillhouse Capital has broken the record for Asia private equity fundraising by collecting $10.6 billion for its most recent vehicle. But how will the firm put all this money to work?
Meituan-Dianping gains on debut after $4.2b Hong Kong IPO
Chinese online-to-offline (O2O) lifestyle services platform Meituan-Dianping gained 5.3% on its trading debut in Hong Kong following a HK$33.1 billion ($4.2 billion) IPO.
PE-backed WuXi AppTec targets Hong Kong listing
Wuxi AppTec, a contract pharmaceutical R&D services provider backed by several private equity investors, has filed for a Hong Kong listing less than four months after listing in Shanghai. The size and pricing of the IPO have yet to be decided, but the...
Hillhouse completes $10.6b fundraise
Hillhouse Capital has closed its latest fund – which will make healthcare, consumer, technology, and services investments globally, but with a focus on Asia – with commitments of $10.6 billion.
China's Nio trades up after smaller-than-expected US IPO
Chinese electric vehicle (EV) maker Nio – which claims its premium vehicle is cheaper and better quality than the Tesla Model X – ended its first day of trading in New York 5.4% above the IPO price following a $1 billion offering.
Meituan-Dianping targets $4.4b IPO, promises domestic focus
Meituan-Dianping, China’s leading online-to-offline (O2O) lifestyle services platform, is looking to raise up to HK$34.6 billion ($4.4 billion) in its Hong Kong IPO, while emphasizing that it will focus on its core domestic business rather than pushing...
Hillhouse leads $55m round for Chinese online education start-up
Kaochong, a Chinese online learning services provider that targets university students, has secured a $55 million Series D funding round led by Hillhouse Capital, with participation from Tencent Holdings and Matrix Partners China.
Qiming, Hillhouse back China's Jacobio Pharma
Chinese drug maker Jacobio has secured a $55 million Series C funding round led by Qiming Venture Partners and Hillhouse Capital, with participation from Prudence Investment Management.
GPs support $590m investment in take-private target China Biologic
China Biologic Products, a US-listed biopharmaceuticals player that was subject to two take-private offers, said it was set to raise $590 million by issuing new shares to investors including Centurium Capital, CITIC Capital, and Hillhouse Capital.
GA, Hillhouse lead $120m Series C for Chinese co-working space
MyDreamPlus, a Beijing-based co-working space provider, has raised $120 million in Series C funding led by General Atlantic (GA) and Hillhouse Capital.
Chinese second-hand goods trading platform raises $65m
Sequoia Capital China has led an extended Series B round worth $65 million for Xiangwushuo, a Chinese online trading platform for second-hand goods. The company, which was founded as recently as 2017, has now raised $110 million in cumulative funding.
Chinese electric car maker Xpeng raises $587m
Primavera Capital Group and Morningside Ventures have led a RMB4 billion ($587 million) Series B-plus funding round for Chinese electric car manufacturer Xpeng Motors, working alongside the company’s chairman and CEO, Xiaopeng He.
Chinese AI player Yitu raises another $100m
Yitu Technology, a Chinese artificial intelligence (AI) start-up, has received $100 million in funding from China Industrial Asset Management (CIAM). It comes a month after the company raised a Series C-plus round of $200 million.
TPG leads $60m Series C for China's Moretickets
TPG Capital has led a $60 million Series C funding round for Moretickets, a Chinese events ticketing platform operator.
Tencent, Sequoia join $80m Series B for Australia's Airwallex
Australian financial technology company Airwallex has closed an $80 million Series B funding round with participation from existing investors Tencent Holdings and Sequoia Capital China.
Cancer drug developer Innovent Biologics files for HK IPO
Innovent Biologics, a Chinese drug developer company with a number of PE backers, has filed for an IPO in Hong Kong under recently introduced rules allowing listings by biotech companies with no revenue or profits.
Uxin trades up on debut after $225m US IPO
Chinese used car trading platform Uxin Group gained 10% on its first day of trading on NASDAQ following a $225 million IPO that was scaled back in terms of size and pricing.
Meituan-Dianping set for bumper Hong Kong listing
Meituan-Dianping, China’s leading online-to-offline (O2O) platform that offers lifestyle services ranging from hotel booking to food delivery to bike-sharing, has filed for an IPO in Hong Kong.